Medicine and Dentistry
Recombinant Erythropoietin
100%
Erythropoietin
100%
Pure Red Cell Aplasia
100%
Patient
85%
Therapeutic Procedure
71%
Anemia
42%
Development
28%
Combination Therapy
28%
Antibody
28%
Neutralizing Antibody
28%
Complication
14%
Immunosuppressive Treatment
14%
Precursor
14%
Hemoglobin
14%
Transfusion
14%
Diagnosis
14%
Erythrocyte Transfusion
14%
Circulation
14%
Immunosuppressive Drug
14%
Immunoassay
14%
Chronic Kidney Disease
14%
Graft Rejection
14%
Kidney Transplantation
14%
Nephropathy
14%
Blood Transfusion
14%
Iron Overload
14%
Reticulocyte
14%
Transferrin Saturation
14%
Cells
14%
Experience
14%
Bone Marrow
14%
Syndrome
14%
INIS
patients
100%
erythropoietin
100%
antibodies
66%
kidneys
50%
anemias
50%
transfusions
50%
therapy
33%
diseases
33%
levels
16%
humans
16%
organs
16%
losses
16%
blood cells
16%
bone marrow
16%
blood
16%
precursor
16%
immunoassay
16%
affinity
16%
iron
16%
hemoglobin
16%
saturation
16%
transferrin
16%
reticulocytes
16%
Pharmacology, Toxicology and Pharmaceutical Science
Erythropoietin
100%
Recombinant Erythropoietin
100%
Pure Red Cell Anemia
100%
Anemia
42%
Immunosuppressive Agent
28%
Antibody
28%
Neutralizing Antibody
28%
Complication
14%
Transferrin
14%
Chronic Kidney Failure
14%
Kidney Disease
14%
Hemoglobin
14%
Graft Rejection
14%
Iron Poisoning
14%
Syndrome
14%
Immunoassay
14%
Immunology and Microbiology
Erythropoietin
100%
Cells
100%
Epoetin Beta
87%
Immunosuppressive Drug
25%
Monospecific Antibody
25%
Neutralizing Antibody
25%
Development
25%
Blood Transfusion
12%
Precursor
12%
Transplant Rejection
12%
Kidney Transplantation
12%
Electric Potential
12%
Immunoassay
12%
Hemocyte
12%
Circulation
12%
Reticulocyte Count
12%
Kidney
12%
Experience
12%
Saturation
12%